Assessment of the Rosacea Prevalence in the General Population

NCT02292797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2014-11-17

No results posted yet for this study

Summary

Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.

Conditions

  • Rosacea

Interventions

OTHER

Prevalence assessment

Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Fabien AUDIBERT, Bsc · Galderma R&D

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-02-28
Completion
2014-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292797 on ClinicalTrials.gov